Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma

Patent ·
OSTI ID:1531460
; ;
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.
Research Organization:
Univ. of Missouri, Columbia, MO (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
FG02-93ER61661
Assignee:
The Curators of the University of Missouri (Columbia, MO)
Patent Number(s):
6,607,709
Application Number:
09/686,700
OSTI ID:
1531460
Country of Publication:
United States
Language:
English

References (36)

[111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: Receptor bindingin vitro andin vivo journal September 1994
A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma journal December 1990
Oxo-complexes of rhenium(V) journal January 1966
Tissue sulfhydryl groups journal May 1959
Synthesis, Characterization and Crystal Structures of Technetium(V)-Oxo Complexes Useful in Nuclear Medicine. 1. Complexes of Mercaptoacetylglycylglycylglycine (MAG3) and Its Methyl Ester Derivative (MAG3OMe) journal March 1995
Technetium (V) and rhenium (V) complexes of 2,3-bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological properties journal July 1990
Novel metal-binding proteins by design journal May 1995
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. journal June 1988
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation journal January 1991
Influence of α-MSH terminal amino acids on binding affinity and biological activity in melanoma cells journal January 1994
Rhenium(V) oxo complexes relevant to technetium renal imaging agents derived from mercaptoacetylglycylglycylaminobenzoic acid isomers. Structural and molecular mechanics studies journal June 1992
Homodimeric and Heterodimeric Bis(amino thiol) Oxometal Complexes with Rhenium(V) and Technetium(V). Control of Heterodimeric Complex Formation and an Approach to Metal Complexes that Mimic Steroid Hormones journal April 1994
Oxygen atom transfer among rhenium, sulfur, and phosphorus. Characterization and reactivity of Re(O)Cl3(Me2S)(OPPh3) and Re(O)Cl3(CNCMe3)2 journal July 1987
In situ melanin assay for MSH using mouse B16 melanoma cells in culture journal November 1986
The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma journal February 1992
Cyclic Melanotropins. 9. 7-D-Phenylalanine Analogues of the Active-Site Sequence journal May 1985
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions journal November 1992
Synthesis and copper(II)-binding properties of the N-terminal peptide of human α-fetoprotein journal February 1989
Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs journal May 1997
Stability and Conformational Analysis of Tc-RC160 and Re-RC160:  Experimental and Theoretical Analysis of the Influence of Metal Complexation on the Structural Requisites for Activity journal January 1996
Restart procedures for the conjugate gradient method journal December 1977
Fluorine-18-labeled [Nle4,d-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue journal February 1997
Metalloantibodies journal August 1990
The Design of Metal-Binding Sites in Proteins journal June 1993
Design and characterization of  -melanotropin peptide analogs cyclized through rhenium and technetium metal coordination journal October 1998
Recent Developments in Peptide Drug Delivery to the Brain journal July 1992
Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents journal April 1995
Characterization of the Iron-binding Site in Mammalian Ferrochelatase by Kinetic and Mössbauer Methods journal November 1995
Radioreceptor Assay for α;-Msh Using Mouse B16 Melanoma Cells journal January 1988
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. journal April 1993
Molecular design to mimic the copper(II) transport site of human albumin: studies of equilibria between copper(II) and glycylglycyl- L -histidine- N -methyl amide and comparison with human albumin journal April 1976
Design, Synthesis, and Conformation of Superpotent and Prolonged Acting Melanotropins journal May 1993
Protein Stabilization by Engineered Metal Chelation journal October 1991
Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms journal August 1996
Structure proof of syn/anti isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium journal October 1990
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. journal October 1980

Similar Records

Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
Patent · Mon Jan 19 23:00:00 EST 2004 · OSTI ID:1531467
Amino acid analogs for tumor imaging
Patent · Tue Sep 15 00:00:00 EDT 1998 · OSTI ID:672678
Amino acid analogs for tumor imaging
Patent · Tue Oct 06 00:00:00 EDT 1998 · OSTI ID:675835

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE